Predicting Drug–Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling-Reference-Cited by-同舟云学术

Predicting Drug–Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling

Published:2018-12-19 Issue:11 Volume:219 Page:1735-1742
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Rajoli Rajith K R¹^ORCID,Curley Paul¹,Chiong Justin¹,Back David¹,Flexner Charles²,Owen Andrew¹,Siccardi Marco¹

Affiliation:

1. Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom

2. Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, Maryland

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/219/11/1735/28560108/jiy726.pdf

Reference43 articles.

1. World Health Organization. Global tuberculosis report.http://www.who.int/tb/publications/global_report/en/ . Accessed 1 August 2018.

2. Joint United Nations Programme on HIV/AIDS. Fact sheet.http://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf. Accessed 1 February 2018.

3. Risk and prognostic significance of tuberculosis in patients from the TREAT Asia HIV observational database;Zhou;BMC Infect Dis,2009

4. Outcome of tuberculosis treatment in HIV-positive adults diagnosed through active versus passive case-finding;Balcha;Glob Health Action,2015

5. An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection;Ahmad Khan;Clin Infect Dis,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical pharmacology considerations and drug–drug interactions with long‐acting cabotegravir and rilpivirine relevant to sub‐Saharan Africa;British Journal of Clinical Pharmacology;2024-06-25

2. Physiologically based Pharmacokinetic Model Validated to Enable Predictions Of Multiple Drugs in a Long-acting Drug-combination Nano-Particles (DcNP): Confirmation with 3 HIV Drugs, Lopinavir, Ritonavir, and Tenofovir in DcNP Products;Journal of Pharmaceutical Sciences;2024-06

3. Two-drug regimens for the treatment of HIV in Africa;The Lancet HIV;2024-06

4. Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics;Expert Review of Clinical Pharmacology;2024-02-14

5. Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy;British Journal of Clinical Pharmacology;2024-02-10